| Product Name: | VP3.15 dihydrobromide |
| Catalog Number: | M28112 |
| CAS Number: | 1281681-33-1 |
| Formula: | C20H24Br2N4OS |
| Molecular Weight: | 528.3 |
| Form: | Solid |
| Solubility: | DMSO 62.5 mg/mL (ultrasonic) |
| Storage: | 4°C, dry, sealed |
| Chemical Structure: | ![]() |
| Description: | VP3.15 dihydrobromide is a potent, orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE)7- glycogen synthase kinase (GSK)3 inhibitor, with IC50s of 1.59 μM and 0.88 μM for PDE7 and GSK-3, respectively. VP3.15 dihydrobromide has neuroprotective and neuroreparative activities, thus as potential combined anti-inflammatory and pro-remyelinating therapies for multiple sclerosis (MS). |
| Stability and Solubility Advice: | Information concerning product stability, particularly in solution, has rarely been reported and in most cases we can only offer a general guide. We recommend that stock solutions, once prepared, are stored aliquoted in tightly sealed vials and used within 1 month. Avoid repeated freeze and thaw cycles. Storage conditions for some special products should refer to their storage details. |